EIF4EBP3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.970800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.152400E-01
Normal-vs-Stage2
8.205400E-01
Normal-vs-Stage3
1.172600E-01
Normal-vs-Stage4
4.785400E-01
Stage1-vs-Stage2
8.983800E-01
Stage1-vs-Stage3
2.987200E-01
Stage1-vs-Stage4
8.588800E-01
Stage2-vs-Stage3
1.714040E-01
Stage2-vs-Stage4
7.189200E-01
Stage3-vs-Stage4
6.919600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.479800E-01
Normal-vs-AfricanAmerican
9.118400E-01
Normal-vs-Asian
2.754200E-01
Caucasian-vs-AfricanAmerican
8.445600E-01
Caucasian-vs-Asian
1.449750E-01
AfricanAmerican-vs-Asian
1.418630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.224600E-01
Normal-vs-Female
9.535200E-01
Male-vs-Female
2.578400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.782600E-01
Normal-vs-Age(41-60Yrs)
9.665000E-01
Normal-vs-Age(61-80Yrs)
9.335400E-01
Normal-vs-Age(81-100Yrs)
2.854600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.449000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.594600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.058400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.587000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.274400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.996500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.658600E-01
Normal-vs-Daily Drinker
4.888000E-01
Normal-vs-Weekly Drinker
5.816000E-01
Normal-vs-Occasional Drinker
9.620000E-01
Normal-vs-Social Drinker
9.825200E-01
Non Drinker-vs-Daily Drinker
3.715600E-01
Non Drinker-vs-Weekly Drinker
5.629600E-01
Non Drinker-vs-Occasional Drinker
6.249000E-01
Non Drinker-vs-Social Drinker
5.785200E-01
Daily Drinker-vs-Weekly Drinker
8.630200E-01
Daily Drinker-vs-Occasional Drinker
2.199400E-01
Daily Drinker-vs-Social Drinker
2.378600E-01
Weekly Drinker-vs-Occasional Drinker
3.652600E-01
Weekly Drinker-vs-Social Drinker
3.806200E-01
Occasional Drinker-vs-Social Drinker
9.087200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.328400E-01
Normal-vs-Grade 2
1.292610E-01
Normal-vs-Grade 3
2.453400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.201000E-03
Grade 1-vs-Grade 3
1.916310E-02
Grade 1-vs-Grade 4
6.328400E-01
Grade 2-vs-Grade 3
9.171600E-01
Grade 2-vs-Grade 4
1.292610E-01
Grade 3-vs-Grade 4
2.453400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.264200E-01
Normal-vs-NonDiabetic
7.998400E-01
Diabetic-vs-NonDiabetic
9.206600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.541600E-01
Normal-vs-NoPancreatitis
8.822800E-01
Pancreatitis-vs-NoPancreatitis
8.951500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.479000E-01
Normal-vs-N1
8.721800E-01
N0-vs-N1
7.471000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.988200E-01
Normal-vs-TP53-NonMutant
9.342400E-01
TP53-Mutant-vs-TP53-NonMutant
1.964160E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
